ENTPD1 and systemic lupus erythematosus: CD39 and CD73 convert ATP into the immunosuppressive molecule eADO, playing critical roles in immune regulation across a variety of diseases, including rheumatoid arthritis, lupus, allergic airway diseases, inflammatory digestive tract disorders, and alcohol-related liver disease [29, 179–182].